Telecare Market

Telecare Market Size, Share & Trends Analysis Report By Type (Activity Monitoring, Remote Medication Management), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts

Published Date: May - 2025 | Publisher: MIR | No of Pages: 240 | Industry: healthcare | Format: Report available in PDF / Excel Format

View Details Buy Now 2999 Download Free Sample Ask for Discount Request Customization

Telecare Market Size & Trends

The size of the global telecare market was estimated at USD 4.71 billion in 2024 and is expected to grow at a CAGR of 4.79% during 2025-2030.
The rising development of technology to offer more streamlined and better healthcare services to patients is expected to propel the market in the forecast years.

Key Highlights
North America commanded the telecare market with the highest revenue share of 49.13% in 2024.
The U.S. held the highest market revenue share in North America in 2024, driven by the demand for remote healthcare services.
The remote medication management type segment dominated the market with the highest revenue share of 50.97% in 2024 and is expected to grow at the highest CAGR during the forecast period.
For example, in March 2023, Royal Philips launched Philips Virtual Care Management, providing extensive sets of flexible solutions and services for health systems, providers, payers, and employer groups to connect and care for patients effectively from anywhere. Moreover, rising awareness for keeping body fit and boosting the penetration rate of the internet and smartphones also drive market growth.

Furthermore, technological advancements in digital health, telecommunication, and electronic health record systems also play a crucial role in boosting the adoption of telecare devices for expanding rehabilitation, health, and wellness services. Additionally, the increasing volume of health apps for monitoring activity and ongoing enhancements in the quality of apps by developers is also anticipated to propel the market growth.

Additionally, telecare services assist in health monitoring among the elderly. The technology and software employed by telecare remote monitoring centers can monitor and support older individuals with abnormally behaving, which will increase their uptake. In addition, the increasing geriatric population across the globe is expected to propel the market for telecare during the forecast years. For instance, according to the World Health Organization (WHO), by 2030, one in six people is expected to be aged over 60 years across the world. Moreover, some telecare technologies track the environmental conditions and unconsciousness of the older adult and automatically trigger the required response. These kinds of technological advancements thereby further support market growth.

Telecare is an integral component of the broader telehealth ecosystem. It is centered on the support of persons, especially the elderly and those with chronic ailments, in their day-to-day health needs using technology. These include services like monitoring of activities, management of medication remotely, and systems for emergency response, all for the purpose of sustaining independence and improving quality of life. The uptake of telehealth has grown substantially, thanks to waivers that have enabled more services to be provided via this channel and guaranteed payment to service providers. It has proved safe and effective with high satisfaction rates among both clinicians and patients. 

It is spurred by government efforts aimed at enhancing the accessibility of healthcare and minimizing healthcare expenditure. Several governments have introduced programs to promote the uptake of telemedicine services and remote patient monitoring. For example, the U.S. Centers for Medicare and Medicaid Services (CMS) has introduced a number of initiatives to foster telemedicine uptake, including the Medicare Telehealth Program. These initiatives have provided a supportive environment for telecare companies to thrive and expand. Other drivers of growth in the telecare market are technological advancements in artificial intelligence and machine learning, which allow more precise and tailored remote care services, and widening use of cloud-based solutions, which allow data exchange and storage with ease.

Market Size

Report Coverage & Deliverables

  • Competitive benchmarking
  • Historical data & forecasts
  • Company revenue shares
  • Regional opportunities
  • Latest trends & dynamics

Market Concentration & Characteristics

Telecare business is distinguished by a great rate of innovation through technological evolution, shifting patients' needs, and the urgency to find inexpensive answers. The market is under rapid evolution as constantly new technology and products hit the market. Progress in AI and ML enables higher-level patient remote monitoring solutions to be built, AI-based telecare mobile applications to sift information and create specific insights to transmit to physicians. For example, in February 2022, virtual care and digital therapeutics firm Biofourmis debuted Biofourmis Care. This tech-enabled care management service delivers remote care to people with chronic diseases. It has automated medication management that helps care teams adjust medications remotely, providing customized therapy to every patient.

Regulations, in particular the 1996 Health Insurance Portability and Accountability Act (HIPAA) and subsequent amendments through the Health Information Technology for Economic and Clinical Health (HITECH) Act, have a positive influence on market growth. These regulations are vital for ensuring the safe handling and privacy of electronic health information and in setting the operational context and the compliance requirements for telecare services, with particular relevance in the U.S.

The telecare market is dominated by a moderate degree of merger and acquisition (M&A) activities by prominent companies. Telecare industry leaders have taken over small firms to acquire new technology, skills, and customers. For example, in April 2024, OMRON Healthcare, Co., Ltd. acquired Luscii Healthtech, an online health and remote consultation service platform. This acquisition is helping Luscii build an end-to-end service that collaboratively supports healthcare professionals, ranging from doctors to hospitals, all under a single integrated platform.

The telecare market is experiencing high levels of product growth, fueled by advancements in technologies like artificial intelligence, the Internet of Things (IoT), and cloud computing. New products and services are being developed to address the increasing need for remote patient monitoring, virtual care, and individualized health management. For example, Pylo Health in January 2024, the remote patient monitoring device company, and Prevounce partner, announced two new leading-edge patient devicesthe Pylo 900-LTE and the Pylo 200-LTE, weight scale and blood pressure monitor.

Type Insights

The segment of remote medication management captured the highest market revenue share of50.97% in 2024 and is expected to grow at the highest CAGR during the forecast period. It is driven by various factors like an aging population, rising incidences of chronic diseases, increasing use of elderly telecare applications and technological changes. Activity monitor devices provide real-time tracking and analysis of a person's movements so that caregivers and healthcare professionals can track the activity and health of their patients remotely. For example, in October 2023, ActiGraph launched a revolutionary new generation of Bluetooth Smart activity monitors, the wGT3X-BT, with wireless communication, data capture, and wear time screening features. When used with the ActiLife software platform and the ActiLife Mobile app, this cutting-edge device provides the most innovative features available in the marketplace.

Besides, the combination of artificial intelligence and machine learning algorithms boosts the capabilities of these devices so that they can identify patterns and anomalies in behavior that could suggest underlying health problems or emergency conditions. Consequently, demand for activity monitoring solutions has exploded in the telecare sector, fueling considerable growth and innovation in this sector.

The activity monitoring space is expected to expand at the high CAGR during the forecast period, driven by the rise in technological advancements and healthcare access and outcomes. Through integration of digital platforms and smart devices, remote medication management solution provides better medication compliance, dose tracking, and real-time communication between healthcare professionals and patients. For example, Garmin Malaysia introduced the HRM-Fit in March 2024, an innovative heart rate monitor tailored for women. Designed with a clip-on feature, it can be clipped onto medium and high-support sports bras in a way that maximizes comfort while tracking real-time heart rate and exercise data with accuracy. This growth trend is set to continue as healthcare systems focus on remote monitoring and management solutions to maximize patient care and minimize healthcare expenditure.

Regional Insights

North America led the telecare market with the highest revenue percentage of 49.13% in 2024. This is due to various reasons like the extensive penetration of smartphones and the internet, increasing awareness among people to take care of physical health and the adoption of remote healthcare services. Further, the rising incidence of chronic diseases in conjunction with a growing geriatric population are some of the key drivers that are expected to propel the market growth in this region. Apart from that, the growing number of telecare providers and presence of dominant players in the U.S. are also contributing towards adoption of these services in this region.

U.S. Telecare Market Trends
The U.S. telecare market reflected the highest revenue share in the North American market in 2024 due to the need for remote healthcare services. The Food and Drug Administration (FDA) governs with regulatory surveillance, scrutinizing telecare technologies for approval through robust mechanisms guaranteeing efficacy and safety. For example, in March 2024, Analog Devices, Inc. announced the U.S. Food and Drug Administration (FDA) clearance of the 510(k) submission of its Sensinel Cardiopulmonary Management System. The small wearable device is a remote, non-invasive monitoring system that takes cardiopulmonary measurements, facilitating remote management of conditions like heart failure. The approval process is usually undertaken after extensive evaluations of device function, data security, and compliance with regulatory specifications. This tough regulatory environment guarantees the effectiveness and reliability of telecare solutions, ensuring sustained market growth.

Europe Telecare Market Trends
The Europe telecare market will experience a high CAGR during the forecast period. The telecare industry in Europe will be transformed by innovation in the form of wearable devices, remote monitoring systems, and telemedicine platforms, ushering in a new era of healthcare delivery that facilitates independence and enhances access to care for citizens across Europe. These advancements facilitate real-time monitoring of health, timely interventions, and better communication between patients and healthcare professionals, fueling the expansion of the European telecare market. For example, in March 2023, Fractyl Health launched the Revita+ telehealth program. The program integrates behavioral suggestions with Revita treatment for Type 2 diabetes. These solutions now provide high-end capabilities like wearable sensors for tele-monitored monitoring, machine learning-based rehabilitation programs, and virtual reality-based therapy interventions.

The UK telecare market is expected to record at a high CAGR over the forecast period, driven by growing uptake of remote healthcare services. Leading players have taken strategic initiatives to increase their market reach through acquisitions and collaborations. For example, in November 2023, AstraZeneca launched Evinova, a new health-tech company that aims to drive life sciences innovation faster and better, with the goal of better patient outcomes. Evinova has an emphasis on building digital solutions, such as remote monitoring of patients and digital therapeutics, with a strong pipeline of emerging products across these fields. These programs are intended to expand product and service capabilities, meeting the increasing demand for telecare services in the UK. With an emphasis on innovation and customer-focused solutions, such businesses are spearheading market expansion and defining the future of telecare in the UK.

Asia Pacific Telecare Market Trends
Asia Pacifictelecare market is expected to exhibit at the highest CAGR during the forecast period due to a high population base and expanding need for remote management of healthcare. Also, expansion in users of the internet and -expanding smartphone penetration is expected to lead to the growth of the market during the forecast period in Asia Pacific. In addition to that, mounting government support in an effort to adopt digital health platforms is supporting growth in this region.

The telecare market in South Korea is likely to record a significant CAGR throughout the forecast period. The South Korean government initiated a pilot program in the initial half of 2018 with core investments in the digitalization of the health system to enhance digital uptake in healthcare. Additionally, high rates of smartphone penetration are likely to drive growth in the market. As per a report by South Korea's Ministry of Science and ICT, smartphone penetration in South Korea stood at 96% in 2022.

Latin America Telecare Market Trends
The Latin American telecare market is expected to see at a significant CAGR during the forecast period. Focusing on increasing access to healthcare services in remote and underserved regions, telecare technology is becoming more popular. Emerging technologies like mobile health apps, elderly telecare apps, and wearable devices provide cost-effective and timely healthcare alternatives, contributing to market growth throughout Latin America.

The Argentina telecare market is expected to record a significant CAGR over the forecast period. Trends like the rising use of digital health technologies, government efforts towards enhancing healthcare accessibility, and increasing prevalence of chronic diseases are driving demand for telecare solutions across the country. The Argentinian government emphasizes ensuring access to healthcare across underdeveloped regions of the nation by digitalizing healthcare, such as telehealth and management of EHR. Argentina raised investments in digital health during March 2021 in order to bridge the loopholes in the healthcare ecosystem.

Middle East & Africa Telecare Market Trends
Middle East and Africatelcare market is expected to observe at a significant CAGR through the forecast period. South Africa, Saudi Arabia, and UAE in the Middle East are thriving. Developments in healthcare infrastructure are likely to implement digital health in these nations. With the development of technology and enhanced accessibility, telecare services are increasingly available throughout the region, meeting the rising demand for convenient and effective healthcare services.

Kuwait telecare market is expected to record a significant CAGR over the forecast period. Kuwait's healthcare industry is witnessing an increased demand for telecare solutions because of various driving factors. Growth in chronic diseases and a rising geriatric population are increasing the demand for remote patient monitoring as well as customized healthcare solutions. Furthermore, increasing healthcare expenses are leading to the implementation of cost-saving telecare solutions in order to enhance patient outcomes and ease the burden of the healthcare system.

Key Telecare Company Insights

The key players in the market have been involved in mergers and acquisitions to increase their share and provide innovative solutions for users, which is anticipated to boost the market's growth during the forecast period.

Market Analysis

Key Telecare Companies

The following are the leading companies in the telecare market. These companies collectively hold the largest market share and dictate industry trends. 

  • Teladoc Health, Inc.
  • Abbott Laboratories
  • Johnson and Johnson
  • AstraZeneca PLC
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • Merck and Co., Inc.
  • Pfizer, Inc.
  • Sanofi
  • Samsung Electronics Co. Ltd
  • Qualcomm Technologies, Inc.
  • Orange
  • Google (Alphabet), Inc
  • Allscripts
  • Airstrip Technologies, Inc.
  • AT&T
  • Apple, Inc.

Recent Developments

  • In December 2024, business-to-business technology company Skyresponse AB entered into a partnership with telecommunications company OneCo Technologies AS. The two companies have entered into this partnership to leverage each other's strengths in order to provide innovative, integrated telecare solutions for hospitals, institutions, independent living, and care homes in the public and private sectors.

    In June of 2024, Ascom launched the Activity Monitoring solution that is specifically suited for long-term care facilities. This cutting-edge software offers an all-encompassing solution in monitoring the residents' health by allowing early recognition and forecasting of any deterioration of their well-being.

    In March 2023, Royal Philips launched Philips Virtual Care Management, providing a broad portfolio of flexible solutions and services for payers, employer groups, and providers to effectively engage and support patients from anywhere.

    In October 2023, ActiGraph introduced a Bluetooth Smart activity monitor, the wGT3X-BT, which will transform the industry with its advanced wireless communication, data capture, and wear time screening features.

Telecare Market Report Scope

Report Attribute

Details

Market size value in 2025

USD 5.02 billion

Revenue forecast in 2030

USD 6.34 billion

Growth rate

CAGR of 4.79% from 2025 to 2030

Base year for estimation

2024

Historical data

2018 - 2023

Forecast data

2025 - 2030

Quantitative units

Revenue in USD million/billion, and CAGR from 2025 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Type, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; Mexico; UK; Germany; Spain; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait

Key companies profiled

Teladoc Health, Inc.; Abbott Laboratories; Johnson and Johnson; AstraZeneca PLC; F. Hoffmann-La Roche Ltd.; Novartis AG; Bristol-Myers Squibb Company; GlaxoSmithKline plc; Merck and Co., Inc.; Pfizer, Inc.; Sanofi; Samsung Electronics Co. Ltd; Qualcomm Technologies, Inc.; Orange; Google (Alphabet), Inc.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Global Telecare Market Report Segmentation

Type Outlook (Revenue, USD Million, 2018 - 2030)

    • Activity Monitoring

    • Remote Medication Management

  • Regional Outlook (Revenue, USD Million, 2018 - 2030)

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • UK

      • Germany

      • France

      • Italy

      • Spain

      • Denmark

      • Norway

      • Sweden

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • South Korea

      • Thailand

    • Latin America

      • Brazil

      • Argentina

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Table of Content

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                        1.1.1. Segment scope
                        1.1.2. Regional scope
                        1.1.3. Estimates and forecast timeline
                    1.2. Research Methodology
                    1.3. Information Procurement
                        1.3.1. Purchased database
                        1.3.2. GVR’s internal database
                        1.3.3. Secondary sources
                        1.3.4. Primary research
                        1.3.5. Details of primary research
                    1.4. Information or Data Analysis
                        1.4.1. Data analysis models
                    1.5. Market Formulation & Validation
                    1.6. Model Details
                        1.6.1. Commodity flow analysis (Model 1)
                            1.6.1.1. Approach 1: Commodity flow approach
                    1.7. Research Assumptions
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Type outlook
                        2.2.2. Regional outlook
                    2.3. Competitive Insights
Chapter 3. Telecare Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Aging population and elderly care needs for telecare
                            3.2.1.2. Technological improvements in AI and ML
                            3.2.1.3. Advances in wearable health technology
                            3.2.1.4. Growing shift to home healthcare services
                            3.2.1.5. Increased focus on chronic disease management
                        3.2.2. Market restraint analysis
                            3.2.2.1. Privacy and security concerns over patient data
                            3.2.2.2. Complexity of regulatory compliance
                            3.2.2.3. Lack of standardization across platforms
                            3.2.2.4. Limited insurance reimbursement for telecare services
                        3.2.3. Market opportunity analysis
                            3.2.3.1. Leveraging ai, big data, and predictive analytics
                            3.2.3.2. Collaborations with healthcare providers and insurers
                            3.2.3.3. Increased focus on mental health and remote counseling
                        3.2.4. Market challenges analysis
                            3.2.4.1. Connectivity and infrastructure gaps in rural areas
                            3.2.4.2. Resistance from healthcare providers and traditional systems
                    3.3. Telecare: Market Analysis Tools
                        3.3.1. Industry analysis - Porter’s
                        3.3.2. PESTLE analysis
                    3.4. Telecare Market: Accomplishments and Opportunities Across the Health System Sectors
                    3.5. Analysis on Start-ups and Established Companies in Telecare Market
                    3.6. Regulatory Landscape, By Country
                        3.6.1. Regulatory overview
                        3.6.2. Health data privacy and security laws
                        3.6.3. Telemedicine licensing and reimbursement policies
                        3.6.4. Government initiatives and support
                        3.6.5. Emerging trends in regulatory compliance
                    3.7. Value Chain Analysis
                        3.7.1. Telecare value chain overview
                        3.7.2. Key stakeholders and their roles
                        3.7.3. Technology providers and platforms
                        3.7.4. Service delivery and interoperability
                        3.7.5. Distribution and supply chain management
                        3.7.6. Revenue streams and business models
                        3.7.7. Challenges in the value chain
                    3.8. Technology Landscape
                        3.8.1. Technological advancements driving telecare
                        3.8.2. Telecare software and applications
                        3.8.3. Data analytics and artificial intelligence
                        3.8.4. Wearable devices and IoT integration
                        3.8.5. Telecommunication infrastructure
                    3.9. Case Study Analysis
                    3.10. Funding/Investment Trends Scenario
                        3.10.1. Venture capital (VC) deal activity
                        3.10.2. Top 10 digital health VC deals in 2024
                        3.10.3. Annual equity funding & deals
                        3.10.4. Quarterly equity funding & deals
                        3.10.5. Quarter funding & deals by global region
                        3.10.6. Percent of quarterly deals by global region
                        3.10.7. Percent of quarterly deals by investor group
                        3.10.8. Annual average & median deal size
                        3.10.9. Annual median deal size by global region
                        3.10.10. Annual median deal size by investor group
                        3.10.11. Annual mega-round funding & deals
                        3.10.12. Quarterly funding & deals from mega-rounds (deals worth usd 100 million+)
                        3.10.13. Quarter mega-round funding & deals by global region
                        3.10.14. Quarterly mega-round deals by global region
                        3.10.15. Quarterly mega-rounds as percentage of funding
                        3.10.16. Quarter top equity deals
                        3.10.17. Annual percentage of deals by deal stage
                        3.10.18. Quarter regional deal shares by deal stage
                        3.10.19. Annual median funding by deal stage
                        3.10.20. Quarter top seed/angel deals
                        3.10.21. Quarter top series A deals
                        3.10.22. Quarter top series B deals
                        3.10.23. Quarter top series C deals
                        3.10.24. Quarter top series D deals
                        3.10.25. Quarter top series E+ deals
                    3.11. Unicorn Funding Trends in Digital Health
                        3.11.1. Quarterly new & total unicorns (private companies valued at USD 1 billion+)
                        3.11.2. Quarter new & total unicorns by global region
                        3.11.3. Quarterly new unicorns by global region
                        3.11.4. Quarter top unicorns by valuation
                    3.12. Exit Trends in Digital Health Market
                        3.12.1. Annual exits
                        3.12.2. Quarterly exits
                        3.12.3. Percent of quarterly exits by global region
                        3.12.4. Quarter top M&A exits
                        3.12.5. Quarter top IPOs
                    3.13. Key Investors Analysis in the Digital Health Landscape
                        3.13.1. Quarter top investors by company count
                        3.13.2. Quarter top VCs by company count
                        3.13.3. Quarter top corporate VCs (CVCs) by company count
                    3.14. Key Investment Geographic Trends in Digital Health Market
                        3.14.1. U.S. Trends
                            3.14.1.1. Annual funding & deals
                            3.14.1.2. Quarterly funding & deals
                            3.14.1.3. Annual percentage of deals by deal stage
                            3.14.1.4. Quarter top equity deals
                            3.14.1.5. Annual exits
                            3.14.1.6. Quarterly exists
                            3.14.1.7. Quarter top investors by company count
                        3.14.2. Asia Trends
                            3.14.2.1. Annual funding & deals
                            3.14.2.2. Quarterly funding & deals
                            3.14.2.3. Annual percentage of deals by deal stage
                            3.14.2.4. Quarter top equity deals
                            3.14.2.5. Annual exits
                            3.14.2.6. Quarterly exists
                            3.14.2.7. Quarter top investors by company count
                        3.14.3. China
                        3.14.4. Japan
                        3.14.5. Europe Trends
                            3.14.5.1. Annual funding & deals
                            3.14.5.2. Quarterly funding & deals
                            3.14.5.3. Annual percentage of deals by deal stage
                            3.14.5.4. Quarter top equity deals
                            3.14.5.5. Annual exits
                            3.14.5.6. Quarterly exists
                            3.14.5.7. Quarter top investors by company count
                        3.14.6. UK
Chapter 4. Telecare Market Segment Analysis, By Type, 2018-2030 (USD Million)
                    4.1. Definition and Scope
                    4.2. Type Market Share Analysis, 2024 & 2030
                    4.3. Segment Dashboard
                    4.4. Global Telecare Market, by Type, 2018 to 2030
                    4.5. Activity Monitoring
                        4.5.1. Activity Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.6. Remote Medication Management
                        4.6.1. Remote Medication Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Telecare Market Segment Analysis, By Region, 2018- 2030 (USD Million)
                    5.1. Regional Market Share Analysis, 2024 & 2030
                    5.2. Regional Market Dashboard
                    5.3. Regional Market Snapshot
                    5.4. Telecare Market Share by Region, 2024 & 2030:
                    5.5. North America
                        5.5.1. North America telecare market, 2018 - 2030 (USD Million)
                        5.5.2. U.S.
                            5.5.2.1. Key Country Dynamics
                            5.5.2.2. Regulatory Scenario
                            5.5.2.3. Competitive Scenario
                            5.5.2.4. U.S. telecare market, 2018 - 2030 (USD Million)
                        5.5.3. Canada
                            5.5.3.1. Key Country Dynamics
                            5.5.3.2. Regulatory Scenario
                            5.5.3.3. Competitive Scenario
                            5.5.3.4. Canada telecare market, 2018 - 2030 (USD Million)
                        5.5.4. Mexico
                            5.5.4.1. Key Country Dynamics
                            5.5.4.2. Regulatory Scenario
                            5.5.4.3. Competitive Scenario
                            5.5.4.4. Mexico telecare market, 2018 - 2030 (USD Million)
                    5.6. Europe
                        5.6.1. Europe telecare market, 2018 - 2030 (USD Million)
                        5.6.2. UK
                            5.6.2.1. Key Country Dynamics
                            5.6.2.2. Regulatory Scenario
                            5.6.2.3. Competitive Scenario
                            5.6.2.4. UK telecare market, 2018 - 2030 (USD Million)
                        5.6.3. Germany
                            5.6.3.1. Key Country Dynamics
                            5.6.3.2. Regulatory Scenario
                            5.6.3.3. Competitive Scenario
                            5.6.3.4. Germany telecare market, 2018 - 2030 (USD Million)
                        5.6.4. France
                            5.6.4.1. Key Country Dynamics
                            5.6.4.2. Regulatory Scenario
                            5.6.4.3. Competitive Scenario
                            5.6.4.4. France telecare market, 2018 - 2030 (USD Million)
                        5.6.5. Italy
                            5.6.5.1. Key Country Dynamics
                            5.6.5.2. Regulatory Scenario
                            5.6.5.3. Competitive Scenario
                            5.6.5.4. Italy telecare market, 2018 - 2030 (USD Million)
                        5.6.6. Spain
                            5.6.6.1. Key Country Dynamics
                            5.6.6.2. Regulatory Scenario
                            5.6.6.3. Competitive Scenario
                            5.6.6.4. Spain telecare market, 2018 - 2030 (USD Million)
                        5.6.7. Norway
                            5.6.7.1. Key Country Dynamics
                            5.6.7.2. Regulatory Scenario
                            5.6.7.3. Competitive Scenario
                            5.6.7.4. Norway telecare market, 2018 - 2030 (USD Million)
                        5.6.8. Sweden
                            5.6.8.1. Key Country Dynamics
                            5.6.8.2. Regulatory Scenario
                            5.6.8.3. Competitive Scenario
                            5.6.8.4. Sweden telecare market, 2018 - 2030 (USD Million)
                        5.6.9. Denmark
                            5.6.9.1. Key Country Dynamics
                            5.6.9.2. Regulatory Scenario
                            5.6.9.3. Competitive Scenario
                            5.6.9.4. Denmark telecare market, 2018 - 2030 (USD Million)
                    5.7. Asia Pacific
                        5.7.1. Asia Pacific telecare market, 2018 - 2030 (USD Million)
                        5.7.2. Japan
                            5.7.2.1. Key Country Dynamics
                            5.7.2.2. Regulatory Scenario
                            5.7.2.3. Competitive Scenario
                            5.7.2.4. Japan telecare market, 2018 - 2030 (USD Million)
                        5.7.3. China
                            5.7.3.1. Key Country Dynamics
                            5.7.3.2. Regulatory Scenario
                            5.7.3.3. Competitive Scenario
                            5.7.3.4. China telecare market, 2018 - 2030 (USD Million)
                        5.7.4. India
                            5.7.4.1. Key Country Dynamics
                            5.7.4.2. Regulatory Scenario
                            5.7.4.3. Competitive Scenario
                            5.7.4.4. India telecare market, 2018 - 2030 (USD Million)
                        5.7.5. Australia
                            5.7.5.1. Key Country Dynamics
                            5.7.5.2. Regulatory Scenario
                            5.7.5.3. Competitive Scenario
                            5.7.5.4. Australia telecare market, 2018 - 2030 (USD Million)
                        5.7.6. South Korea
                            5.7.6.1. Key Country Dynamics
                            5.7.6.2. Regulatory Scenario
                            5.7.6.3. Competitive Scenario
                            5.7.6.4. South Korea telecare market, 2018 - 2030 (USD Million)
                        5.7.7. Thailand
                            5.7.7.1. Key Country Dynamics
                            5.7.7.2. Regulatory Scenario
                            5.7.7.3. Competitive Scenario
                            5.7.7.4. Thailand telecare market, 2018 - 2030 (USD Million)
                    5.8. Latin America
                        5.8.1. Latin America telecare market, 2018 - 2030 (USD Million)
                        5.8.2. Brazil
                            5.8.2.1. Key Country Dynamics
                            5.8.2.2. Regulatory Scenario
                            5.8.2.3. Competitive Scenario
                            5.8.2.4. Brazil telecare market, 2018 - 2030 (USD Million)
                        5.8.3. Argentina
                            5.8.3.1. Key Country Dynamics
                            5.8.3.2. Regulatory Scenario
                            5.8.3.3. Competitive Scenario
                            5.8.3.4. Argentina telecare market, 2018 - 2030 (USD Million)
                    5.9. MEA
                        5.9.1. MEA telecare market, 2018 - 2030 (USD Million)
                        5.9.2. South Africa
                            5.9.2.1. Key Country Dynamics
                            5.9.2.2. Regulatory Scenario
                            5.9.2.3. Competitive Scenario
                            5.9.2.4. South Africa telecare market, 2018 - 2030 (USD Million)
                        5.9.3. Saudi Arabia
                            5.9.3.1. Key Country Dynamics
                            5.9.3.2. Regulatory Scenario
                            5.9.3.3. Competitive Scenario
                            5.9.3.4. Saudi Arabia telecare market, 2018 - 2030 (USD Million)
                        5.9.4. UAE
                            5.9.4.1. Key Country Dynamics
                            5.9.4.2. Regulatory Scenario
                            5.9.4.3. Competitive Scenario
                            5.9.4.4. UAE telecare market, 2018 - 2030 (USD Million)
                        5.9.5. Kuwait
                            5.9.5.1. Key Country Dynamics
                            5.9.5.2. Regulatory Scenario
                            5.9.5.3. Competitive Scenario
                            5.9.5.4. Kuwait telecare market, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
                    6.1. Recent Developments & Impact Analysis, By Key Market Participants
                    6.2. Company Categorization
                    6.3. Company Position Analysis
                    6.4. Company Evaluation Metrix
                    6.5. Company Profiles
                        6.5.1. Teladoc Health, Inc.
                            6.5.1.1. Company overview
                            6.5.1.2. Financial performance
                            6.5.1.3. Product benchmarking
                            6.5.1.4. Strategic initiatives
                        6.5.2. Abbott Laboratories
                            6.5.2.1. Company overview
                            6.5.2.2. Financial performance
                            6.5.2.3. Product benchmarking
                            6.5.2.4. Strategic initiatives
                        6.5.3. Johnson and Johnson
                            6.5.3.1. Company overview
                            6.5.3.2. Financial performance
                            6.5.3.3. Product benchmarking
                            6.5.3.4. Strategic initiatives
                        6.5.4. AstraZeneca PLC
                            6.5.4.1. Company overview
                            6.5.4.2. Financial performance
                            6.5.4.3. Product benchmarking
                            6.5.4.4. Strategic initiatives
                        6.5.5. F. Hoffmann-La Roche Ltd.
                            6.5.5.1. Company overview
                            6.5.5.2. Financial performance
                            6.5.5.3. Product benchmarking
                            6.5.5.4. Strategic initiatives
                        6.5.6. Novartis AG
                            6.5.6.1. Company overview
                            6.5.6.2. Financial performance
                            6.5.6.3. Product benchmarking
                            6.5.6.4. Strategic initiatives
                        6.5.7. NeoRehab
                            6.5.7.1. Company overview
                            6.5.7.2. Financial performance
                            6.5.7.3. Product benchmarking
                            6.5.7.4. Strategic initiatives
                        6.5.8. Bristol-Myers Squibb Company
                            6.5.8.1. Company overview
                            6.5.8.2. Financial performance
                            6.5.8.3. Product benchmarking
                            6.5.8.4. Strategic initiatives
                        6.5.9. GlaxoSmithKline plc
                            6.5.9.1. Company overview
                            6.5.9.2. Financial performance
                            6.5.9.3. Product benchmarking
                            6.5.9.4. Strategic initiatives
                        6.5.10. Merck and Co., Inc.
                            6.5.10.1. Company overview
                            6.5.10.2. Financial performance
                            6.5.10.3. Product benchmarking
                            6.5.10.4. Strategic initiatives
                        6.5.11. Pfizer, Inc.
                            6.5.11.1. Company overview
                            6.5.11.2. Financial performance
                            6.5.11.3. Product benchmarking
                            6.5.11.4. Strategic initiatives
                        6.5.12. Sanofi
                            6.5.12.1. Company overview
                            6.5.12.2. Financial performance
                            6.5.12.3. Product benchmarking
                            6.5.12.4. Strategic initiatives
                        6.5.13. Samsung Electronics Co. Ltd
                            6.5.13.1. Company overview
                            6.5.13.2. Financial performance
                            6.5.13.3. Product benchmarking
                            6.5.13.4. Strategic initiatives
                        6.5.14. Qualcomm Technologies, Inc.
                            6.5.14.1. Company overview
                            6.5.14.2. Financial performance
                            6.5.14.3. Product benchmarking
                            6.5.14.4. Strategic initiatives
                        6.5.15. Orange
                            6.5.15.1. Company overview
                            6.5.15.2. Financial performance
                            6.5.15.3. Product benchmarking
                            6.5.15.4. Strategic initiatives
                        6.5.16. Google (Alphabet), Inc
                            6.5.16.1. Company overview
                            6.5.16.2. Financial performance
                            6.5.16.3. Product benchmarking
                            6.5.16.4. Strategic initiatives
                        6.5.17. Allscripts
                            6.5.17.1. Company overview
                            6.5.17.2. Financial performance
                            6.5.17.3. Product benchmarking
                            6.5.17.4. Strategic initiatives
                        6.5.18. Apple, Inc.
                            6.5.18.1. Company overview
                            6.5.18.2. Financial performance
                            6.5.18.3. Product benchmarking
                            6.5.18.4. Strategic initiatives
                        6.5.19. AT&T
                            6.5.19.1. Company overview
                            6.5.19.2. Financial performance
                            6.5.19.3. Product benchmarking
                            6.5.19.4. Strategic initiatives
                        6.5.20. Airstrip Technologies, Inc
                            6.5.20.1. Company overview
                            6.5.20.2. Financial performance
                            6.5.20.3. Product benchmarking
                            6.5.20.4. Strategic initiatives

 

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global telecare market, by type, 2018 - 2030 (USD Million)
Table 4 North America telecare market, by country, 2018 - 2030 (USD Million)
Table 5 North America telecare market, by type, 2018 - 2030 (USD Million)
Table 6 U.S. telecare market, by type, 2018 - 2030 (USD Million)
Table 7 Canada telecare market, by type, 2018 - 2030 (USD Million)
Table 8 Mexico telecare market, by type, 2018 - 2030 (USD Million)
Table 9 Europe telecare market, by country, 2018 - 2030 (USD Million)
Table 10 Europe telecare market, by type, 2018 - 2030 (USD Million)
Table 11 UK telecare market, by type, 2018 - 2030 (USD Million)
Table 12 Germany telecare market, by type, 2018 - 2030 (USD Million)
Table 13 France telecare market, by type, 2018 - 2030 (USD Million)
Table 14 Italy telecare market, by type, 2018 - 2030 (USD Million)
Table 15 Spain telecare market, by type, 2018 - 2030 (USD Million)
Table 16 Norway telecare market, by type, 2018 - 2030 (USD Million)
Table 17 Denmark telecare market, by type, 2018 - 2030 (USD Million)
Table 18 Sweden telecare market, by type, 2018 - 2030 (USD Million)
Table 19 Asia Pacific telecare market, by country, 2018 - 2030 (USD Million)
Table 20 Asia Pacific telecare market, by type, 2018 - 2030 (USD Million)
Table 21 Japan telecare market, by type, 2018 - 2030 (USD Million)
Table 22 China telecare market, by type, 2018 - 2030 (USD Million)
Table 23 India telecare market, by type, 2018 - 2030 (USD Million)
Table 24 Australia telecare market, by type, 2018 - 2030 (USD Million)
Table 25 South Korea telecare market, by type, 2018 - 2030 (USD Million)
Table 26 Thailand telecare market, by type, 2018 - 2030 (USD Million)
Table 27 Latin America telecare market, by country, 2018 - 2030 (USD Million)
Table 28 Latin America telecare market, by type, 2018 - 2030 (USD Million)
Table 29 Brazil telecare market, by type, 2018 - 2030 (USD Million)
Table 30 Argentina telecare market, by type, 2018 - 2030 (USD Million)
Table 31 Middle East & Africa telecare market, by country, 2018 - 2030 (USD Million)
Table 32 Middle East & Africa telecare market, by type, 2018 - 2030 (USD Million)
Table 33 South Africa telecare market, by type, 2018 - 2030 (USD Million)
Table 34 Saudi Arabia telecare market, by type, 2018 - 2030 (USD Million)
Table 35 UAE telecare market, by type, 2018 - 2030 (USD Million)
Table 36 Kuwait telecare market, by type, 2018 - 2030 (USD Million)

List Tables Figures

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.